Yoshihiko Morikawa

731 total citations
77 papers, 443 citations indexed

About

Yoshihiko Morikawa is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yoshihiko Morikawa has authored 77 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 16 papers in Epidemiology. Recurrent topics in Yoshihiko Morikawa's work include Kawasaki Disease and Coronary Complications (15 papers), Coronary Artery Anomalies (11 papers) and Respiratory viral infections research (7 papers). Yoshihiko Morikawa is often cited by papers focused on Kawasaki Disease and Coronary Complications (15 papers), Coronary Artery Anomalies (11 papers) and Respiratory viral infections research (7 papers). Yoshihiko Morikawa collaborates with scholars based in Japan, United States and Australia. Yoshihiko Morikawa's co-authors include Masaru Miura, Hiroshi Sakakibara, Tetsuji Kaneko, Hiroyuki Yamagishi, Yuho Horikoshi, Toshimasa Obonai, Yuki Yuza, Hiroshi Hataya, Akira Akasawa and Takatoshi Tsuchihashi and has published in prestigious journals such as The Journal of Pediatrics, Epilepsia and Vaccine.

In The Last Decade

Yoshihiko Morikawa

63 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yoshihiko Morikawa Japan 12 197 166 78 62 38 77 443
Irini Mavrou Greece 12 108 0.5× 120 0.7× 139 1.8× 84 1.4× 19 0.5× 19 420
M. Tanguy France 12 91 0.5× 147 0.9× 87 1.1× 41 0.7× 14 0.4× 35 453
Eileen Duggan United States 13 281 1.4× 166 1.0× 80 1.0× 55 0.9× 6 0.2× 28 556
Alok Sharma United States 14 227 1.2× 247 1.5× 68 0.9× 196 3.2× 8 0.2× 57 692
Vincent Labbé France 11 82 0.4× 396 2.4× 98 1.3× 50 0.8× 20 0.5× 29 647
Sema Turan Türkiye 9 78 0.4× 68 0.4× 72 0.9× 36 0.6× 30 0.8× 37 309
Michel Djibré France 13 73 0.4× 251 1.5× 59 0.8× 23 0.4× 14 0.4× 30 451
Bhavna Gupta India 9 80 0.4× 61 0.4× 62 0.8× 38 0.6× 10 0.3× 94 308
Jeremy D. Flynn United States 15 159 0.8× 38 0.2× 90 1.2× 115 1.9× 11 0.3× 43 552
Sourabh Aġġarwal United States 12 199 1.0× 231 1.4× 81 1.0× 270 4.4× 12 0.3× 63 674

Countries citing papers authored by Yoshihiko Morikawa

Since Specialization
Citations

This map shows the geographic impact of Yoshihiko Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiko Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiko Morikawa more than expected).

Fields of papers citing papers by Yoshihiko Morikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshihiko Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiko Morikawa. The network helps show where Yoshihiko Morikawa may publish in the future.

Co-authorship network of co-authors of Yoshihiko Morikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshihiko Morikawa. A scholar is included among the top collaborators of Yoshihiko Morikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshihiko Morikawa. Yoshihiko Morikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hagiwara, Yusuke, et al.. (2025). Procaterol via nebulizer versus metered‐dose inhaler with a spacer for acute asthma exacerbation in children. Pediatrics International. 67(1). e70072–e70072.
2.
Miura, Masaru, Tetsuji Kaneko, Yoshihiko Morikawa, et al.. (2024). Methylprednisolone pulse and prednisolone for intensification of primary treatment in Kawasaki disease patients at high risk of treatment resistance: a multicenter prospective cohort study. European Journal of Pediatrics. 183(10). 4265–4274. 2 indexed citations
3.
Makimoto, Atsushi, Hiroyuki Fujisaki, Kimikazu Matsumoto, et al.. (2024). Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects. Cancers. 16(3). 544–544. 7 indexed citations
4.
Hamada, Riku, Yoshihiko Morikawa, Ryoko Harada, et al.. (2024). Frequency and severity of hyponatremia in healthy children with acute illness. Pediatric Nephrology. 40(3). 765–772.
5.
Makimoto, Atsushi, Motoaki Chin, Katsuyoshi Koh, et al.. (2024). Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial. International Journal of Clinical Oncology. 29(5). 629–637. 1 indexed citations
6.
Matsuki, Eri, et al.. (2023). The Impact of Cold Ambient Temperature in the Pattern of Influenza Virus Infection. Open Forum Infectious Diseases. 10(2). ofad039–ofad039. 5 indexed citations
7.
Morikawa, Yoshihiko, et al.. (2023). The Effects of Sensory Integration Therapy on Children with Neurodevelopmental Disorders. 19(1). 87–95. 1 indexed citations
8.
Morikawa, Yoshihiko, et al.. (2023). Impact of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation. British Journal of Clinical Pharmacology. 89(6). 1852–1861. 1 indexed citations
9.
Matsuyama, Takeshi, Riku Hamada, Yoshihiko Morikawa, et al.. (2023). Reference values for urinary protein, albumin, beta 2-microglobulin, and the alpha 1-microglobulin-to-creatinine ratio in Japanese children. Clinical and Experimental Nephrology. 28(1). 50–57. 6 indexed citations
10.
Hatao, Fumihiko, Masanari Itokawa, Yoshihiko Morikawa, et al.. (2023). Feasibility and Safety of Super Energy-dense Oral Nutritional Supplementation in Postoperative Gastric Cancer Patients. Cancer Diagnosis & Prognosis. 3(4). 514–521.
11.
Kato, Hiroaki, et al.. (2023). Investigation of in-line filter replacement intervals for infusion. Journal of Hospital Infection. 134. 147–152.
12.
13.
Asai, Yuki, et al.. (2022). A Questionnaire Survey on the Current Status of Cooperation between Community Pharmacies and Hospitals in Perioperative Management in Mie Prefecture. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 48(9). 368–378.
14.
Kato, Hideo, Mao Hagihara, Yoshihiko Morikawa, et al.. (2022). Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia. Antibiotics. 11(8). 983–983. 5 indexed citations
15.
Sakakibara, Hiroshi, et al.. (2022). A prospective cohort study of sensorineural hearing loss associated with Kawasaki disease. International Journal of Pediatric Otorhinolaryngology. 163. 111365–111365. 1 indexed citations
16.
Wang, Qianzhi, Yoshihiko Morikawa, Ryo Ueno, et al.. (2021). Prognosis of ultrasonographic low-grade pediatric appendicitis treated with supportive care. Surgery. 170(1). 215–221. 7 indexed citations
17.
Miura, Masaru, Tetsuji Kaneko, Yoshihiko Morikawa, et al.. (2021). Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease. Circulation Cardiovascular Quality and Outcomes. 14(2). e007191–e007191. 24 indexed citations
18.
Morikawa, Yoshihiko, et al.. (2021). Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE. The Journal of Pediatrics. 240. 158–163.e4. 11 indexed citations
19.
Morikawa, Yoshihiko, et al.. (2021). Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease. Vaccine. 39(39). 5680–5687. 5 indexed citations
20.
Morikawa, Yoshihiko, et al.. (2017). Bradycardia Associated with Prednisolone in Children with Severe Kawasaki Disease. The Journal of Pediatrics. 185. 106–111.e1. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irini Mavrou Breakdown of academic impact, for papers by M. Tanguy Breakdown of academic impact, for papers by Eileen Duggan Breakdown of academic impact, for papers by Alok Sharma Breakdown of academic impact, for papers by Vincent Labbé Breakdown of academic impact, for papers by Sema Turan Breakdown of academic impact, for papers by Michel Djibré Breakdown of academic impact, for papers by Bhavna Gupta Breakdown of academic impact, for papers by Jeremy D. Flynn Breakdown of academic impact, for papers by Sourabh Aġġarwal
Rankless by CCL
2026